Drugs / 4'-epiDoxorubicin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00930891 Background | Sep 2009 → Jul 2012 | small cell lung carcinoma | French Cooperative Thoracic Intergroup | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 4'-epiDoxorubicin | “4'-epiDoxorubicin 30 mg/m² D1; Etoposide 75 mg/m² D1 to D3” NCT00930891 ↗ |